Señales en vivo de AGRX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 13:38):

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States...

Stats
Volumen de hoy	18 955.00
Volumen promedio	754 415
Capitalización de mercado	2.63M
EPS	$-1.510 ( 2024-03-28 )
Próxima fecha de ganancias	( $-0.510 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0600
ATR14	$0.0160 (4.17%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-03	Coiante Scott M	Buy	20 000	Common Stock
2023-08-16	Coiante Scott M	Sell	0	Common Stock
2023-06-28	Welsh Amy	Buy	13 500	Common Stock
2023-06-28	Welsh Amy	Buy	4 500	Employee Stock Option (Right to Buy)
2023-06-28	Korner Paul	Buy	13 500	Common Stock

INSIDER POWER
99.60
Last 98 transactions
Buy: 13 666 273 \| Sell: 187 248

Agile Therapeutics Inc Correlación

10 Correlaciones Más Positivas
CFRX	0.977
WISA	0.969
PXS	0.967
FWRD	0.967
IONM	0.964
PETS	0.962
IRDM	0.962
BHTG	0.961
CYXT	0.96
IVAC	0.959

10 Correlaciones Más Negativas
CRZN	-0.984
HERA	-0.981
AGGR	-0.98
HERAU	-0.979
LDHA	-0.978
TBSA	-0.976
LVRA	-0.976
ACQR	-0.974
LEGA	-0.974
AHRN	-0.973

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Agile Therapeutics Inc Finanzas

Annual	2023
Ingresos:	$19.59M
Beneficio Bruto:	$10.62M (54.18 %)
EPS:	$-0.00670

FY	2023
Ingresos:	$19.59M
Beneficio Bruto:	$10.62M (54.18 %)
EPS:	$-0.00670

FY	2022
Ingresos:	$10.88M
Beneficio Bruto:	$4.05M (37.19 %)
EPS:	$-58.79

FY	2021
Ingresos:	$4.10M
Beneficio Bruto:	$-6.62M (-161.35 %)
EPS:	$-0.884

Financial Reports:

No articles found.

Agile Therapeutics Inc

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

Actualizaciones en tiempo real para Agile Therapeutics Inc [AGRX]

Upcoming Earnings Alert